Astellas Pharma's total assets for Q3 2022 were ¥2.51T, an increase of Infinity% from the previous quarter. DE:YPH total liabilities were ¥943.52B for the fiscal quarter, a Infinity% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.